e-learning
resources
Munich 2006
Monday 04.09.2006
Respiratory muscles
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD
A. H. Remels, H. R. Gosker, P. Schrauwen, J. Willems, R. Broekhuizen, S. Kersten, A. M. Schols (Maastricht, Wageningen, Netherlands)
Source:
Annual Congress 2006 - Respiratory muscles
Session:
Respiratory muscles
Session type:
Oral Presentation
Number:
2148
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. H. Remels, H. R. Gosker, P. Schrauwen, J. Willems, R. Broekhuizen, S. Kersten, A. M. Schols (Maastricht, Wageningen, Netherlands). Reduced expression of peroxisome proliferator-activated receptors (PPARs) in skeletal muscle of patients with COPD. Eur Respir J 2006; 28: Suppl. 50, 2148
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
The physiology of breathlessness
Related content which might interest you:
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Source: Eur Respir J 2008; 31: 502-508
Year: 2008
Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006
Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir Rev 2006; 15: 211-212
Year: 2006
Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Source: Eur Respir J 2007; 30: 245-252
Year: 2007
The effects of exercise training on peroxisome proliferator-activated receptor (PPAR) expression in skeletal muscle in COPD
Source: Annual Congress 2009 - Emerging physiology behind pulmonary rehabilitation
Year: 2009
The effect of COPD on muscle structure and function
Source: Annual Congress 2006 - COPD: a systemic disease affecting the muscles
Year: 2006
Ubiquitin expression is up-regulated in peripheral muscle in elderly patients with COPD
Source: Annual Congress 2006 - COPD comorbidity
Year: 2006
Respiratory and skeletal muscles in chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=201
Year: 2006
Relationship between the tissue depletion pattern and muscle mass, muscle strength and inflammation in COPD patients
Source: Annual Congress 2006 - COPD and systemic inflammation
Year: 2006
Role of soluble α-klotho on lung and skeletal muscle function in chronic obstructive pulmonary disease
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016
Effect of pulmonary rehabilitation on muscle inflammation and muscle insulin-like growth factor-I in COPD
Source: Annual Congress 2006 - Physiological responses to rehabilitation
Year: 2006
Carnitine deficiency in chronic obstructive pulmonary disease patients
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Vitamin D receptor genotypes influence quadriceps strength in COPD
Source: Annual Congress 2007 - Pathophysiology of respiratory muscles
Year: 2007
Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 19: 617-625
Year: 2002
Cardiac muscle mass and function are associated with altered body composition in patients with COPD
Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Year: 2007
The influence of comorbid factors on muscle function, morphology and metabolism in COPD
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=99
Year: 2003
Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?
Source: Eur Respir J 2007; 30: 191-193
Year: 2007
Systemic inflammation is associated with mitophagy signalling in skeletal muscle of COPD patients
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006
Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: 52S-63S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept